Development of a Prediction Model for Healthy Life Years Without Activity Limitation: National Cross-sectional Study.

activity limitation application tool cross-sectional study health policy health promotion healthy life years life expectancy machine learning prediction model

Journal

JMIR public health and surveillance
ISSN: 2369-2960
Titre abrégé: JMIR Public Health Surveill
Pays: Canada
ID NLM: 101669345

Informations de publication

Date de publication:
17 05 2023
Historique:
received: 20 02 2023
accepted: 18 04 2023
revised: 27 03 2023
medline: 19 5 2023
pubmed: 17 5 2023
entrez: 17 5 2023
Statut: epublish

Résumé

In some countries, including Japan-the leading country in terms of longevity, life expectancy has been increasing; meanwhile, healthy life years have not kept pace, necessitating an effective health policy to narrow the gap. The aim of this study is to develop a prediction model for healthy life years without activity limitations and deploy the model in a health policy to prolong healthy life years. The Comprehensive Survey of Living Conditions, a cross-sectional national survey of Japan, was conducted by the Japanese Ministry of Health, Labour and Welfare in 2013, 2016, and 2019. The data from 1,537,773 responders were used for modelling using machine learning. All participants were randomly split into training (n=1,383,995, 90%,) and test (n=153,778, 10%) subsets. Extreme gradient boosting classifier was implemented. Activity limitations were set as the target. Age, sex, and 40 types of diseases or injuries were included as features. Healthy life years without activity limitations were calculated by incorporating the predicted prevalence rate of activity limitations in a life table. For the wide utility of the model in individuals, we developed an application tool for the model. In the groups without (n=1,329,901) and with (n=207,872) activity limitations, the median age was 47 (IQR 30-64) and 69 (IQR 54-80) years, respectively (P<.001); female sex comprised 51.3% (n=681,794) in the group without activity limitations and 56.9% (n=118,339) in the group with activity limitations (P<.001). A total of 42 features were included in the feature set. Age had the highest impact on model accuracy, followed by depression or other mental diseases; back pain; bone fracture; other neurological disorders, pain, or paralysis; stroke, cerebral hemorrhage, or infarction; arthritis; Parkinson disease; dementia; and other injuries or burns. The model exhibited high performance with an area under the receiver operating characteristic curve of 0.846 (95% CI 0.842-0.849) with exact calibration for the average probability and fraction of positives. The prediction results were consistent with the observed values of healthy life years for both sexes in each year (range of difference between predictive and observed values: -0.89 to 0.16 in male and 0.61 to 1.23 in female respondents). We applied the prediction model to a regional health policy to prolong healthy life years by adjusting the representative predictors to a target prevalence rate. Additionally, we presented the health condition without activity limitations index, followed by the application development for individual health promotion. The prediction model will enable national or regional governments to establish an effective health promotion policy for risk prevention at the population and individual levels to prolong healthy life years. Further investigation is needed to validate the model's adaptability to various ethnicities and, in particular, to countries where the population exhibits a short life span.

Sections du résumé

BACKGROUND
In some countries, including Japan-the leading country in terms of longevity, life expectancy has been increasing; meanwhile, healthy life years have not kept pace, necessitating an effective health policy to narrow the gap.
OBJECTIVE
The aim of this study is to develop a prediction model for healthy life years without activity limitations and deploy the model in a health policy to prolong healthy life years.
METHODS
The Comprehensive Survey of Living Conditions, a cross-sectional national survey of Japan, was conducted by the Japanese Ministry of Health, Labour and Welfare in 2013, 2016, and 2019. The data from 1,537,773 responders were used for modelling using machine learning. All participants were randomly split into training (n=1,383,995, 90%,) and test (n=153,778, 10%) subsets. Extreme gradient boosting classifier was implemented. Activity limitations were set as the target. Age, sex, and 40 types of diseases or injuries were included as features. Healthy life years without activity limitations were calculated by incorporating the predicted prevalence rate of activity limitations in a life table. For the wide utility of the model in individuals, we developed an application tool for the model.
RESULTS
In the groups without (n=1,329,901) and with (n=207,872) activity limitations, the median age was 47 (IQR 30-64) and 69 (IQR 54-80) years, respectively (P<.001); female sex comprised 51.3% (n=681,794) in the group without activity limitations and 56.9% (n=118,339) in the group with activity limitations (P<.001). A total of 42 features were included in the feature set. Age had the highest impact on model accuracy, followed by depression or other mental diseases; back pain; bone fracture; other neurological disorders, pain, or paralysis; stroke, cerebral hemorrhage, or infarction; arthritis; Parkinson disease; dementia; and other injuries or burns. The model exhibited high performance with an area under the receiver operating characteristic curve of 0.846 (95% CI 0.842-0.849) with exact calibration for the average probability and fraction of positives. The prediction results were consistent with the observed values of healthy life years for both sexes in each year (range of difference between predictive and observed values: -0.89 to 0.16 in male and 0.61 to 1.23 in female respondents). We applied the prediction model to a regional health policy to prolong healthy life years by adjusting the representative predictors to a target prevalence rate. Additionally, we presented the health condition without activity limitations index, followed by the application development for individual health promotion.
CONCLUSIONS
The prediction model will enable national or regional governments to establish an effective health promotion policy for risk prevention at the population and individual levels to prolong healthy life years. Further investigation is needed to validate the model's adaptability to various ethnicities and, in particular, to countries where the population exhibits a short life span.

Identifiants

pubmed: 37195737
pii: v9i1e46634
doi: 10.2196/46634
pmc: PMC10233441
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e46634

Informations de copyright

©Masahiro Nishi, Reo Nagamitsu, Satoaki Matoba. Originally published in JMIR Public Health and Surveillance (https://publichealth.jmir.org), 17.05.2023.

Références

J Nutr Health Aging. 2019;23(8):717-724
pubmed: 31560029
Lancet. 2012 Dec 15;380(9859):2129-43
pubmed: 23245605
Lancet Glob Health. 2015 Nov;3(11):e712-23
pubmed: 26475018
Health Informatics J. 2018 Sep;24(3):227-244
pubmed: 27496863
Lancet. 2012 Dec 15;380(9859):2144-62
pubmed: 23245606
J Epidemiol. 2012;22(3):199-204
pubmed: 22343332
JAMA. 2006 Nov 15;296(19):2343-50
pubmed: 17105797
Int J Environ Res Public Health. 2017 May 15;14(5):
pubmed: 28505140
BMC Public Health. 2019 Sep 9;19(1):1238
pubmed: 31500600
Lancet. 2017 Sep 23;390(10101):1521-1538
pubmed: 28734670
Int J Epidemiol. 2016 Aug;45(4):1260-1270
pubmed: 27488415
Lancet. 2022 Sep 3;400(10354):744-756
pubmed: 36049493
Eur J Clin Nutr. 2019 Mar;73(3):395-400
pubmed: 30104730
PLoS One. 2022 Nov 3;17(11):e0277260
pubmed: 36327332
J Epidemiol. 2017 Feb;27(2):75-79
pubmed: 28142015
PLoS One. 2016 Oct 27;11(10):e0165106
pubmed: 27788163
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Lancet Digit Health. 2020 Oct;2(10):e516-e525
pubmed: 32984797
HSMHA Health Rep. 1971 Apr;86(4):347-54
pubmed: 5554262
Geriatr Gerontol Int. 2016 Jun;16(6):670-8
pubmed: 26044713
Lancet Reg Health West Pac. 2021 Mar 02;9:100110
pubmed: 34379708

Auteurs

Masahiro Nishi (M)

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Department of Health and Welfare, Kyoto Prefectural Government, Kyoto, Japan.

Reo Nagamitsu (R)

Department of Health and Welfare, Kyoto Prefectural Government, Kyoto, Japan.
Department of Epidemiology for Community Health and Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Satoaki Matoba (S)

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH